Narcolepsy Meeting Focuses on Symptoms, But Some Urge Attention to Underlying Cause

Posted by on Oct 17, 2013 in Awareness

The Pink Sheet, October 7, 2013 Excessive daytime sleepiness, interrupted nighttime sleep and “brain fog” are key symptoms that new drugs developed for the treatment of narcolepsy should target, patients told FDA Sept. 24. During a four-hour meeting held as part of the agency’s patient-focused drug development initiative, dozens of patients and caregivers talked about […]

Load More